This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Mar 26:372:n805.

doi: 10.1136/bmj.n805.

Anti-amyloid trials raise scientific and ethical questions

A David Smith¹

Affiliations

PMID: 33771816
DOI: 10.1136/bmj.n805

Comment

Anti-amyloid trials raise scientific and ethical questions

A David Smith. BMJ. 2021.

. 2021 Mar 26:372:n805.

doi: 10.1136/bmj.n805.

Author

A David Smith¹

Affiliation

¹ Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK.

PMID: 33771816
DOI: 10.1136/bmj.n805

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis.
Ackley SF, Zimmerman SC, Brenowitz WD, Tchetgen Tchetgen EJ, Gold AL, Manly JJ, Mayeda ER, Filshtein TJ, Power MC, Elahi FM, Brickman AM, Glymour MM. Ackley SF, et al. BMJ. 2021 Feb 25;372:n156. doi: 10.1136/bmj.n156. BMJ. 2021. PMID: 33632704 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- scite Smart Citations